BlackRock’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-530,237
| Closed | -$615K | – | 6046 |
|
|
2022
Q2 | $615K | Sell |
530,237
-4,354,080
| -89% | -$4.55M | ﹤0.01% | 4704 |
|
|
2022
Q1 | $5.28M | Sell |
4,884,317
-71,516
| -1% | -$54K | ﹤0.01% | 3924 |
|
|
2021
Q4 | $3.57M | Buy |
4,955,833
+71,656
| +1% | +$58K | ﹤0.01% | 4141 |
|
|
2021
Q3 | $4.4M | Sell |
4,884,177
-11,425
| -0.2% | -$13.8K | ﹤0.01% | 4008 |
|
|
2021
Q2 | $8.13M | Buy |
4,895,602
+1,345,859
| +38% | +$2.25M | ﹤0.01% | 3717 |
|
|
2021
Q1 | $7.42M | Buy |
3,549,743
+477,972
| +16% | +$993K | ﹤0.01% | 3747 |
|
|
2020
Q4 | $3.84M | Buy |
3,071,771
+203,181
| +7% | +$242K | ﹤0.01% | 3806 |
|
|
2020
Q3 | $3.5M | Sell |
2,868,590
-49,709
| -2% | -$60.4K | ﹤0.01% | 3723 |
|
|
2020
Q2 | $3.42M | Buy |
2,918,299
+279,501
| +11% | +$258K | ﹤0.01% | 3667 |
|
|
2020
Q1 | $2.15M | Sell |
2,638,798
-47,645
| -2% | -$50.5K | ﹤0.01% | 3633 |
|
|
2019
Q4 | $2.71M | Sell |
2,686,443
-67,882
| -2% | -$82.3K | ﹤0.01% | 3684 |
|
|
2019
Q3 | $3.88M | Buy |
2,754,325
+96,779
| +4% | +$137K | ﹤0.01% | 3553 |
|
|
2019
Q2 | $3.99M | Buy |
2,657,546
+22,254
| +0.8% | +$34.4K | ﹤0.01% | 3586 |
|
|
2019
Q1 | $4.03M | Sell |
2,635,292
-165,227
| -6% | -$252K | ﹤0.01% | 3483 |
|
|
2018
Q4 | $4.12M | Buy |
2,800,519
+14,014
| +0.5% | +$21.5K | ﹤0.01% | 3452 |
|
|
2018
Q3 | $5.1M | Buy |
2,786,505
+92,454
| +3% | +$179K | ﹤0.01% | 3503 |
|
|
2018
Q2 | $4.96M | Buy |
2,694,051
+2,616,245
| +3,363% | +$4.87M | ﹤0.01% | 3512 |
|
|
2018
Q1 | $156K | Sell |
77,806
-1,414
| -2% | -$1.9K | ﹤0.01% | 4257 |
|
|
2017
Q4 | $87K | Buy |
79,220
+3,272
| +4% | +$3.35K | ﹤0.01% | 4357 |
|
|
2017
Q3 | $87K | Sell |
75,948
-3,052
| -4% | -$3.47K | ﹤0.01% | 4386 |
|
|
2017
Q2 | $102K | Buy |
79,000
+72,389
| +1,095% | +$103K | ﹤0.01% | 4392 |
|
|
2017
Q1 | $13K | Buy |
+6,611
| New | +$14K | ﹤0.01% | 4679 |
|
BlackRock's MBII Position: Q3 2022 in Review
BlackRock sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 530,237 shares — an estimated $615K sold.
BlackRock first reported a position in MBII in Q1 2017 and held it in 22 quarters. The position peaked at $8.13M in Q2 2021. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- BlackRock reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- BlackRock sold 530,237 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $615K.
- BlackRock first reported a position in Marrone Bio Innovations, Inc. in Q1 2017 and held it in 22 quarters.
- BlackRock's Marrone Bio Innovations, Inc. position peaked at $8.13M in Q2 2021.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.